Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
0
2
0
0
OPIANT PHARMACEUTICALS INC
Share · US6837501039 · OPNT (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of OPIANT PHARMACEUTICALS INC
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 83,09 %
Shares Float 4,38 M
Shares Outstanding 5,27 M
Company Profile for OPIANT PHARMACEUTICALS INC Share
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
Company Data
Name OPIANT PHARMACEUTICALS INC
Company Opiant Pharmaceuticals, Inc.
Symbol OPNT
Website
https://www.opiant.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US6837501039
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Roger Crystal
Market Capitalization 109 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 233 Wilshirre Boulevard, 90401 Santa Monica
IPO Date 2007-06-04
Stock Splits
| Date | Split |
|---|---|
| 31.12.2014 | 1:100 |
| 20.08.2009 | 20:1 |
ID Changes
| Date | From | To |
|---|---|---|
| 22.01.2016 | LLTP | OPNT |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | OPNT |
More Shares
Investors who hold OPIANT PHARMACEUTICALS INC also have the following shares in their portfolio:
